What is the clinical evidence from this study?

Study design: Review. Population: NSAID-induced ulcers. Intervention: Misoprostol.

What question did this study set out to answer?

This research evaluates the effectiveness of misoprostol in preventing NSAID-induced ulcers.

January 1, 1992Scandinavian Journal of Rheumatology

Prevention of NSAID-Induced Ulcers by the Coadministration of Misoprostol: Implications in Clinical Practice

View Full Paper

Ask AI

Bookmark

Key result

Misoprostol 400 to 800 micrograms/day is effective in preventing NSAID-induced ulcers without interfering with the analgesic or anti-inflammatory effects of NSAIDs.

Why the study?

Does misoprostol prevent NSAID-induced ulcers in patients taking NSAIDs?

Population

Patients taking NSAIDs, particularly arthritis patients at risk of NSAID-related gastrointestinal ulceration…

Design

Review

Authors

RNR NumoAzienda Universitaria Ospedaliera Consorziale - Policlinico Bari

Discussion

Member takes

Implication

May support misoprostol coadministration in at-risk NSAID users; leaves open confirmation in contemporary RCTs.

Key Points

This research evaluates the effectiveness of misoprostol in preventing NSAID-induced ulcers.
Coadministration of misoprostol (400 to 800 micrograms/day) with NSAIDs in patients at risk for ulcers.
Assessment of gastrointestinal complications associated with NSAIDs.
Identification of high-risk patients for tailored prophylactic therapy.
Misoprostol significantly prevents NSAID-induced ulcers compared to NSAIDs alone.
Most patients experienced mild side effects like transient diarrhea and cramps.
Coadministration of misoprostol with NSAIDs does not compromise the analgesic effect of the NSAIDs.

Structured PICO

Does misoprostol prevent NSAID-induced ulcers in patients taking NSAIDs?

Population

Patients taking NSAIDs, particularly arthritis patients at risk of NSAID-related gastrointestinal ulceration and its associated complications

Intervention

Misoprostol 400 to 800 micrograms/day in divided doses coadministered with NSAIDs after meals

Outcome

Prevention of NSAID-induced ulcers

Misoprostol coadministration (400-800 mcg/day) is recommended to prevent NSAID-induced ulcers in at-risk patients without compromising NSAID efficacy.

Cite This Study

R Numo (1992) conducted a review in NSAID-induced ulcers. Misoprostol was evaluated. Misoprostol 400 to 800 micrograms/day is effective in preventing NSAID-induced ulcers without interfering with the analgesic or anti-inflammatory effects of NSAIDs.

synapsesocial.com/papers/6a6eb752f44fa9f079dc4d6d https://doi.org/10.3109/03009749209101386

View Full Paper

Ask AI

Bookmark

Prevention of NSAID-Induced Ulcers by the Coadministration of Misoprostol: Implications in Clinical Practice

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Prevention of NSAID-Induced Ulcers by the Coadministration of Misoprostol: Implications in Clinical Practice

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Also Consider

Also Consider